Natalia Krześniak

Natalia Krześniak

Auto-generated profile, based on publicly available information

Natalia Krześniak

Department of Plastic and Reconstructive Surgery, Centre of Postgraduate Medical Education, Prof. W. Orlowski Memorial Hospital, Warsaw, Poland

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2020 in Neural Regeneration Research
Verified
Journal Article
Open access
PDF file
NKNatalia E. Krzesniak
Natalia E. Krzesniak
ASAnna Sarnowska
Anna Sarnowska
AFAnna Figiel-Dabrowska
Anna Figiel-Dabrowska
KOKatarzyna Osiak
Katarzyna Osiak
KDKrystyna Domanska-Janik
Krystyna Domanska-Janik
BNBartłomiej H. Noszczyk
Bartłomiej H. Noszczyk
The reconstruction of nerve continuity after traumatic nerve injury is the gold standard in hand surgery. Immediate, tension-free, end-to-end nerve suture ensures the best prognosis. The recovery is mostly promising; however, in a few cases, insufficient outcomes in motor or sensory function are observed. Intra- and extra-fascicular scarring accompanies the nerve regeneration process and limits final outcomes. Secondary nerve release in those cases is recommended. Unfortunately, scarring recurrence cannot be eliminated after secondary revision and neurolysis. The supportive influences of mesenchymal stem cells in the process of nerve regeneration were observed in many preclinical studies. However, a limited number of studies in humans have analyzed the clinical usage of mesenchymal stem cells in peripheral nerve reconstruction and revisions. The objective of this study was to evaluate the effects of undifferentiated adipose-derived stromal/stem cell injection during a last-chance surgery (neurolysis, nerve release) on a previously reconstructed nerve. Three patients (one female, two males; mean age 59 ± 4.5 years at the time of injury), who experienced failure of reconstructions of median and ulnar nerves, were included in this study. During the revision surgery, nerve fascicles were released, and adipose-derived stromal/stem cells were administered through microinjections along the fascicles and around the adjacent tissues after external neurolysis. During 36 months of follow-up, patients noticed gradual signs of sensory and in consequence functional recovery. No adverse effects were observed. Simultaneous nerve release with adipose-derived stromal/stem cells support is a promising method in patients who need secondary nerve release after nerve reconstruction. This method can constitute an alternative procedure in patients experiencing recovery failure and allow improvement in cases of limited nerve regeneration. The study protocol was approved by the Institutional Review Board (IRB) at the Centre of Postgraduate Medical Education (No. 62/PB/2016) on September 14, 2016.

25 October 2025 in Advances in Medical Sciences
Verified
Journal Article
Open access
MSMonika Sypecka
Monika Sypecka
MCMagdalena Chodkowska-Michałowska
Magdalena Chodkowska-Michałowska
DSDorota Sulejczak
Dorota Sulejczak
NKNatalia Krześniak
Natalia Krześniak
MZMarzena Zychowicz
Marzena Zychowicz
Anna SarnowskaAnna Sarnowska
Anna Sarnowska
Despite ongoing debate surrounding mesenchymal stem/stromal cells (MSCs), the number of clinical trials involving MSCs has continued to increase due to their strong therapeutic potential. These cells exhibit immunosuppressive and neuroprotective properties, making them a promising approach for treating neurodegenerative diseases. Given the growing interest in stem cell-based therapies, it is essential to establish specific protocols for manufacturing adipose-derived MSCs. This study outlines the process of obtaining an ATMP cell product from ASCs, evaluating cell quality, isolation efficiency, and optimal conditions for cryopreservation, preparation, and transport. Cells were isolated from fresh, cryopreserved, and 4°C-stored adipose tissue to evaluate how different storage conditions affect cell quality. In addition, cell viability in different transport solutions over time was examined. To evaluate the therapeutic potential of ASCs, cells were cultured in cerebrospinal fluid (CSF) and neural gene and protein expression, as well as the secretome profile, were analysed. Our findings show that isolating ASCs immediately after liposuction yields the highest viable cell count. Adipose tissue can be stored at 4 °C for up to 48 h without affecting cell population doubling time, but cryopreservation negatively impacts ASCs' clonogenicity. For optimal long-term preservation, a medium with 5 % platelet lysate and 10 % DMSO is recommended. Additionally, we found that 0.9 % NaCl is the best transport medium for maintaining cell viability. CSF exposure induced neural markers (NG2, A2B5, Nestin, β-III-tubulin, S-100-β) and morphological changes, suggesting neural-like differentiation. These findings contribute to the development of protocols for MSC therapy in neurodegenerative diseases.

1 October 2014 in Plastic and Reconstructive Surgery
Verified
Journal Article
Closed access
BNBartomiej Noszczyk
Bartomiej Noszczyk
NKNatalia Krzesniak
Natalia Krzesniak

20 January 2025 in Microsurgery
Verified
Journal Article
Open access
NKNatalia Ewa Krzesniak
Natalia Ewa Krzesniak
MZMarzanna Zaleska
Marzanna Zaleska
BMBalazs Mohos
Balazs Mohos
MCManon Czedik‐Eysenberg
Manon Czedik‐Eysenberg
MKMichaela Krammel
Michaela Krammel
CTChieh‐Han John Tzou
Chieh‐Han John Tzou
The Charles procedure (CP) is a potentially devastating treatment; however, in cases of an end stage of untreated or improperly treated lymphedema, it is the ultimate surgical therapy. As a life‐saving solution, it quickly relieves patients with giant, hypertrophic extremities, mostly in ambulation and hygiene maintenance. Nevertheless, long‐term results may disappoint both doctors and patients, who struggle with social stigma, the need for lifelong compression, massive lymphoedema in the distal parts of the feet, badly fitting shoes, excessive skin fibrosis, severe keratinization of skin‐grafted surfaces, periodic lymphorrhea from the resected areas, or acute and chronic inflammation. For these reasons, patients may seek further surgical help, even many years after treatment. This article describes findings in fluorescent lymphography with indocyanine green (ICG‐L) in four patients (49, 56, 56 years old females and 35 years old males) after CP and outcomes of treatment with lymphaticovenous anastomosis (LVA). In all patients, nonresected areas of the dorsum of the feet showed massive lymphedema stage II to III with dermal backflow (DB). In two patients, resected and skin‐grafted areas showed deep subfascial lymphatics with lazy flow and no DB. In the remaining two cases, resected areas showed massive DB. Patients were reluctant to undergo further extensive surgical treatment with lymph node transfers due to the trauma experienced after CP. Since they still struggle with residual lower extremity lymphedema in unresected areas of the lower limbs, we performed minimally invasive, physiologic LVA surgeries in their feet, and in one patient in proximal thighs. In all cases, the postoperative course was uneventful. The treatment brought relief, reducing the circumference of the feet by ~2 cm, and allowed the return to previously used shoes in a follow‐up of 18–36 months. This is the first report of ICG‐L findings in CP patients, who benefit from minimal invasive LVA surgery. This information might help improve the life quality of patients after CP.

1 January 2023 in Postępy Higieny I Medycyny Doświadczalnej
Verified
Journal Article
Open access
PDF file
AŚAneta Ścieżyńska
Aneta Ścieżyńska
Anna SobiepanekAnna Sobiepanek
Anna Sobiepanek
MSMarta Soszyńska
Marta Soszyńska
KŁKrzysztof Łuszczyński
Krzysztof Łuszczyński
MRMarcin Radziszewski
Marcin Radziszewski
JMJacek Malejczyk
Jacek Malejczyk
Introduction: Development of an effective, suitable, and reliable method for both the isolation and culturing of melanocytes is crucial for studies on pathomechanisms of skin diseases originating from melanocyte disorders. In this study, we have investigated the influence of geneticin (G418), a substance used for melanocyte selection, in the view of the frequency of presence of cells such as keratinocytes and fibroblasts, widely known as contaminators of melanocyte-originating cell cultures. Materials and Methods: Study was conducted on primary, freshly isolated melanocytes, keratinocytes, fibroblasts, and melanoma cells as well as on commercially available melanoma cell lines MeWo, G-361, and A375. Cells were cultured in different culture media supplemented with various concentrations of geneticin ranging from 0.05 to 1 mg/mL. Cell viability, proliferation rate and detection of apoptotic/necrotic cells was assessed. Results: Choice of culture media supplemented with various concentrations of geneticin (0.05 mg/mL, 0.1 mg/mL, 0.5 mg/mL and 1 mg/mL) strongly affect viability of melanocytes, fibroblasts, and keratinocytes. Selective culture media without FBS facilitate the process of melanocytes and melanoma pure cell culture, yet without geneticin supplementation are insufficient for complete eradication of fibroblast contamination from cell culture. Conclusions: In this study we provide, for the first time, the dose-response action of keratinocytes and fibroblasts upon geneticin stimulation in different culture media and show that a low concentration (0.05 mg/mL) of geneticin added to the selective culture media may be safely implemented to facilitate the production of melanocyte and melanoma cell cultures that are free from frequent cell contaminants.